Randomized, Single-blind, Cross-over Study Investigating the Non-inferiority of Efficacy and Safety of HyQvia in Comparison With Conventional Subcutaneous Ig Therapy in Multifocal Motor Neuropathy
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Immune globulin (Primary)
- Indications Multifocal motor neuropathy
- Focus Therapeutic Use
- 24 Oct 2016 Status changed from not yet recruiting to recruiting.
- 05 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 24 Sep 2015 New trial record